Barely Significant
← all excerpts

Intensification with Intravenous Ustekinumab in Refractory Crohn's Disease.

J Clin Med · 2024 · PMC10856525 · PMID 38337361

1
hedged sentence
closest p
boldest claim

The sentences

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.